Immediate Impact
1 by Nobel laureates 1 from Science/Nature 55 standout
Citing Papers
Endometriosis Typology and Ovarian Cancer Risk
2024 Standout
Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
Works of John P. Micha being referenced
A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer
2012
Abraxane in the treatment of ovarian cancer: The absence of hypersensitivity reactions
2005
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| John P. Micha | 570 | 486 | 413 | 120 | 1.4k | |
| John V. Brown | 627 | 502 | 467 | 102 | 1.5k | |
| Bram H. Goldstein | 502 | 484 | 446 | 121 | 1.3k | |
| Mark A. Rettenmaier | 567 | 538 | 446 | 128 | 1.5k | |
| Giorgio Giorda | 851 | 481 | 599 | 90 | 1.4k | |
| Britt Erickson | 507 | 285 | 422 | 145 | 1.6k | |
| Glauco Baiocchi | 446 | 546 | 670 | 141 | 1.6k | |
| Bruce Patsner | 544 | 505 | 499 | 103 | 1.2k | |
| Lobna Ouldamer | 549 | 355 | 662 | 143 | 1.3k | |
| Giovanni Di Vagno | 414 | 337 | 354 | 52 | 1.0k | |
| Eva Chalas | 494 | 508 | 514 | 80 | 1.7k |
All Works
Login with ORCID to disown or claim papers
Loading papers...